Search Results for "dapagliflozin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for dapagliflozin. Results 31 to 34 of 34 total matches.
See also: Farxiga, Xigduo

Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
inhibitors with dapagliflozin/saxagliptin (Qtern).7 ▶ Avoid concurrent use of strong CYP3A4 or P-gp inducers ...
View the Table: GLP-1 and GIP/GLP-1 Receptor Agonists for Type 2 Diabetes
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e1-3   doi:10.58347/tml.2024.1708c |  Show IntroductionHide Introduction

Cardiovascular Effects of Some Antidiabetic Drugs

   
The Medical Letter on Drugs and Therapeutics • Aug 14, 2017  (Issue 1527)
to date that dapagliflozin (Farxiga) reduces the incidence of cardiovascular events. THIAZOLIDINEDIONES ...
...
Med Lett Drugs Ther. 2017 Aug 14;59(1527):136-8 |  Show IntroductionHide Introduction

In Brief: Finerenone (Kerendia) for Diabetic Kidney Disease

   
The Medical Letter on Drugs and Therapeutics • Jan 23, 2023  (Issue 1668)
with an eGFR ≥30 mL/ min/1.73 m2 An SGLT2 inhibitor with proven renal benefits (canagliflozin, dapagliflozin ...
Recently published guidelines from the American Diabetes Association (ADA) and the Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group recommend addition of the oral nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone (Kerendia) to standard treatment in patients with type 2 diabetes and chronic kidney disease (CKD).
Med Lett Drugs Ther. 2023 Jan 23;65(1668):15-6   doi:10.58347/tml.2023.1668e |  Show IntroductionHide Introduction

Table: Treatments Considered for COVID-19 (Archived) (online only)

   
The Medical Letter on Drugs and Therapeutics • Apr 06, 2020  (Issue 1595)
Inhibitor dapagliflozin Farxiga Famotidine Pepcid Interferon Ribavirin Betaseron Extavia Rebetol ...
View the Table: Treatments Considered for COVID-19
Med Lett Drugs Ther. 2020 Apr 6;62(1595):e1-289 |  Show IntroductionHide Introduction